Biolife Solutions (BLFS) EBT Margin (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of EBT Margin data on file, last reported at 4.54% in Q1 2026.

• On a quarterly basis, EBT Margin rose 325.0% year-over-year to 4.54% in Q1 2026; TTM through Mar 2026 was 10.42%, a 358.0% decrease from a year earlier, with the FY2025 full-year figure at 12.56%, down 74.0% from the prior year.
• EBT Margin for Q1 2026 stood at 4.54%, down from 17.9% in the prior quarter.
• Over the last five years, EBT Margin for BLFS reached as high as 17.9% in Q4 2025 and fell as low as 219.83% in Q4 2022.
• Historically, EBT Margin has averaged 46.23% across 5 years, with a median of 22.14% in 2022.
• Across the five-year window, EBT Margin plunged 17404 bps in 2022 and surged 17016 bps in 2023, its largest moves.
• Year by year, EBT Margin stood at 219.83% in 2022, then jumped by 43 bps to 126.02% in 2023, then surged by 102 bps to 3.1% in 2024, then soared by 477 bps to 17.9% in 2025, then slumped by 75 bps to 4.54% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 4.54% in Q1 2026, 17.9% in Q4 2025, and 2.5% in Q3 2025.